Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen.
about
The role of EBV in the pathogenesis of Burkitt's Lymphoma: an Italian hospital based surveyGranulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphomaBurkitt lymphoma in adolescents and young adults: management challenges.Primary burkitt lymphoma of the chest wall.Trends in survival of patients with Burkitt lymphoma/leukemia in the USA: an analysis of 3691 cases.Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia.A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma.Indian Council of Medical Research Consensus Document for the Management of Non-Hodgkin's Lymphoma (High Grade).Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma.Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma.Outcomes of patients with Burkitt lymphoma older than age 40 treated with intensive chemotherapeutic regimens.Prolonged low intensity EPOCH-rituximab has improved toxicity in Burkitt lymphoma compared with standard short, high intensity therapyHematopoietic stem cell transplantation for leukemiaBurkitt lymphoma: pathogenesis and immune evasion.Burkitt's lymphoma of stomach: A case report and review of literature.Combination of dexamethasone, high-dose cytarabine, and carboplatin is effective for advanced large-cell non-Hodgkin lymphoma of childhood.Brief intensive therapy for older adults with newly diagnosed Burkitt or atypical Burkitt lymphoma/leukemia.An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study.Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis.EBV-associated lymphomas in adultsImproved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trialPrimary Gastric Burkitt's Lymphoma.Atypical Burkitt's lymphoma transforming from follicular lymphoma.Burkitt lymphoma and atypical Burkitt or Burkitt-like lymphoma: should these be treated as different diseases?HIV-Associated Burkitt Lymphoma: Good Efficacy and Tolerance of Intensive Chemotherapy Including CODOX-M/IVAC with or without Rituximab in the HAART Era.Lessons from the past: opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies.Towards curative therapy in burkitt lymphoma: the role of early african studies in demonstrating the value of combination therapy and CNS prophylaxis.Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients.Effect of rituximab on adult Burkitt's lymphoma: a systematic review and meta-analysis.AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma.Paradigms and Controversies in the Treatment of HIV-Related Burkitt Lymphoma.Controversies in the treatment of Burkitt lymphoma in AIDSTreatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent diseaseTreatment of Burkitt lymphoma in adults.Burkitt's Lymphoma of the Rectosigmoid and Stomach Presenting as Hematochezia.A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial).Xanthogranulomatous Appendicitis Mimicking Residual Burkitt's Lymphoma After Chemotherapy.Outcomes for paediatric Burkitt lymphoma treated with anthracycline-based therapy in Malawi.Neurobiology of pain in children: an overviewHigh cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program.
P2860
Q21093165-36A6BD69-AB3D-492D-B895-B2F672D2CBD2Q24240753-51C00C18-4850-407D-A2AD-84CD335BF92BQ30238965-B8BD3175-9AD1-430E-A16C-3FBF2C55FFD7Q30425404-5AF4CE3C-B514-414A-9B71-C3DC60121163Q30540646-DAA536E3-994F-4DEC-A25E-D18108F0F5D4Q33341768-334EECBC-4B3F-42D8-82F1-3314DA7F608DQ33411059-5C0324C8-53D4-4FFF-8C1D-3A3B96837263Q33583302-C60FE0A1-CFEC-4B30-B4F6-CD5FEF0A1F00Q33806007-E68D2A53-BBAF-4DDE-AEC6-40D4AA6B4A95Q33828585-6FEF832F-B91B-4EB0-9804-5B1ADB256F70Q34018599-CADC1F71-B44D-4BBE-B81F-B674F95F4468Q34028427-89FE4474-FE70-400F-99D1-286ACBF810D0Q34034180-B14F1110-128A-4475-B7D8-228BFF36E1B6Q34189497-A743F91B-2861-4FEF-9AC2-0D9851FEE1D6Q34202044-6181F4DD-ABDA-4070-A56E-C9D1AF85DD42Q34287195-EF8A4FA4-5F51-4A8A-AD7C-71BCE6DB531DQ34522797-C8AA4DAF-47DF-4CCE-AFF8-2B5F09C74654Q34526281-2E2AF2AD-9D31-4D32-AE40-B2BE8DEAD58AQ34627112-25BB8952-CB4E-44FF-845C-C3A219CA652AQ34636601-975BF432-CC4B-4D7D-A19B-955A6F276A74Q34737471-306F2A28-0B3B-411E-A28E-9FD2FF219ACDQ34760470-40BE1512-20C8-44E9-8DFA-DAFD61B41485Q35128743-42735E68-C119-486C-9375-084D8F793C7BQ35384536-277523DE-2899-430E-9375-1BFC7DF69C90Q35606384-70DD25A6-A14F-4B96-A6DB-57B305BCD6EFQ35667279-E82C9711-D69D-4D37-AF30-7C104D6AFDE0Q35687432-78F9E268-B938-4A73-9BB2-D7116414044CQ35750990-EDB9BF9C-E70D-4EC8-8EAE-350067F72893Q35794300-CA6D1612-32A6-42EE-BB07-9B3FA12C5BB3Q35836856-592C87DB-3E37-426C-AB8E-989942C4015CQ35915375-D5E6FE42-2196-41E7-B6AB-7A8F4B27D9DDQ36151295-C166D34D-1F71-459E-B0F3-045873E2BCF5Q36201443-10274B0F-31A0-4743-B2C6-5EEC8B5A1CA5Q36407453-DE5BE8EF-F76E-4EE4-934C-EBDC27043D52Q36592652-A56F0B39-6D62-459D-AB06-1BFA368CFC1FQ36868708-866F3609-2EF5-4E2D-B83C-5D094D63B236Q36896783-6319BE67-E25B-4A56-A627-AADD3AEB53F1Q36944719-31EB488A-AF85-4CD6-AE91-31520EA7D0F0Q37225466-2864BCD9-81A0-4DDF-AB3B-F29D9BB90FFCQ37273182-97A76E63-39E6-4198-B407-D2B411DCDD7D
P2860
Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen.
description
1996 nî lūn-bûn
@nan
1996 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մարտին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Adults and children with small ...... the same chemotherapy regimen.
@ast
Adults and children with small ...... the same chemotherapy regimen.
@en
type
label
Adults and children with small ...... the same chemotherapy regimen.
@ast
Adults and children with small ...... the same chemotherapy regimen.
@en
prefLabel
Adults and children with small ...... the same chemotherapy regimen.
@ast
Adults and children with small ...... the same chemotherapy regimen.
@en
P2093
P1476
Adults and children with small ...... the same chemotherapy regimen.
@en
P2093
J Gootenberg
P304
P356
10.1200/JCO.1996.14.3.925
P407
P577
1996-03-01T00:00:00Z